documents: FDA-2026-N-10429-0006

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2026-N-10429-0006 FDA FDA-2026-N-10429 Reference 5 - Kock, P., Froelich, K., Walter, M., Lang, U., and K.M. Du¨ rsteler, ‘‘A systematic literature review of clinical trials and therapeutic applications of ibogaine,’’ J. Subst. Abuse Treat., 138:108717 (2022), available at doi:10.1016/j.jsat.2021.108717. Supporting & Related Material Background Material 2026-10-06T04:00:00Z 2026 10     2026-10-06T20:44:40Z   0 0 09000064b9635d78

Links from other tables